NLS Pharmaceutics AG
NLSP
$1.53
$0.0553.74%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/20/2025
-
Ticker Report
4/15/2025
-
GuruFocus
4/15/2025
-
GuruFocus
4/15/2025
-
GuruFocus
4/15/2025
-
The Fly
4/15/2025
-
PR Newswire
3/31/2025
-
Benzinga
3/31/2025
-
GuruFocus
3/31/2025
-
TipRanks Financial Blog
3/31/2025
-
Seeking Alpha - Healthcare
3/31/2025
-
TipRanks Financial Blog
3/31/2025
-
The Fly
3/31/2025
-
Accesswire
3/10/2025
-
GuruFocus
3/10/2025
-
PR Newswire
2/27/2025
-
GuruFocus
2/27/2025
-
The Fly
2/27/2025
-
PR Newswire
2/25/2025
-
TipRanks Financial Blog
2/25/2025
-
The Fly
2/25/2025
-
PR Newswire
2/10/2025
-
TipRanks Financial Blog
2/10/2025
-
The Fly
2/10/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, October 18, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
41 44 512 21 50
Address
The Circle 6
Zurich, 8058
Zurich, 8058
Country
Year Founded
Business Description
Sector
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The...
more